As of 2025-07-05, the Relative Valuation of Gossamer Bio Inc (GOSS) is (3.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.24 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -343.6%.
The range of the Relative Valuation is (1.85) - (4.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 18.7x | 13.1x |
| Forward P/E multiples | 8.2x - 21.3x | 13.7x |
| Fair Price | (1.85) - (4.21) | (3.02) |
| Upside | -249.4% - -439.2% | -343.6% |
| Date | P/E |
| 2025-07-03 | -5.50 |
| 2025-07-02 | -5.37 |
| 2025-07-01 | -5.55 |
| 2025-06-30 | -5.46 |
| 2025-06-27 | -5.55 |
| 2025-06-26 | -5.77 |
| 2025-06-25 | -6.03 |
| 2025-06-24 | -6.12 |
| 2025-06-23 | -6.08 |
| 2025-06-20 | -6.39 |
| 2025-06-18 | -5.72 |
| 2025-06-17 | -5.50 |
| 2025-06-16 | -5.68 |
| 2025-06-13 | -5.50 |
| 2025-06-12 | -5.63 |
| 2025-06-11 | -5.72 |
| 2025-06-10 | -5.55 |
| 2025-06-09 | -5.90 |
| 2025-06-06 | -5.90 |
| 2025-06-05 | -5.59 |
| 2025-06-04 | -5.59 |
| 2025-06-03 | -5.41 |
| 2025-06-02 | -5.12 |
| 2025-05-30 | -4.92 |
| 2025-05-29 | -5.01 |
| 2025-05-28 | -5.15 |
| 2025-05-27 | -4.97 |
| 2025-05-23 | -5.32 |
| 2025-05-22 | -5.15 |
| 2025-05-21 | -5.10 |
| 2025-05-20 | -5.23 |
| 2025-05-19 | -4.84 |
| 2025-05-16 | -4.61 |
| 2025-05-15 | -4.66 |
| 2025-05-14 | -4.48 |
| 2025-05-13 | -4.84 |
| 2025-05-12 | -4.88 |
| 2025-05-09 | -4.92 |
| 2025-05-08 | -4.97 |
| 2025-05-07 | -4.86 |
| 2025-05-06 | -4.84 |
| 2025-05-05 | -5.55 |
| 2025-05-02 | -5.23 |
| 2025-05-01 | -4.70 |
| 2025-04-30 | -4.52 |
| 2025-04-29 | -3.91 |
| 2025-04-28 | -3.89 |
| 2025-04-25 | -4.25 |
| 2025-04-24 | -4.34 |
| 2025-04-23 | -3.97 |